Cash & equivalents decreased 76.0%
Cash & equivalents changed -76.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$16.1M→$3.9M4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →CPIX financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Inventory decreased 99.1%
Inventory changed -99.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$3.2M→$29,9354 prior comparisons
Current liabilities increased 46.8%
Current liabilities changed +46.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$24.0M→$35.2M4 prior comparisons
Operating income decreased 322.8%
Operating income changed -322.8% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
-$747,478→-$3.2M3 prior comparisons
Working capital / assets moved 1312 bp lower
Working capital / assets changed -1312 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
10.65%→-2.47%4 prior comparisons
Operating margin moved 2901 bp lower
Operating margin changed -2901 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
-6.90%→-35.91%3 prior comparisons
Current ratio decreased 26.6%
Current ratio changed -26.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
1.3→0.964 prior comparisons
Current assets increased 7.8%
Current assets changed +7.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$31.2M→$33.6M4 prior comparisons
Trade receivables increased 30.1%
Trade receivables changed +30.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$10.3M→$13.4M4 prior comparisons
Research & development decreased 47.4%
Research & development changed -47.4% from the comparable as-filed period.
$1.5M→$772,1623 prior comparisons
Revenue decreased 18.8%
Revenue changed -18.8% from the comparable as-filed period.
$10.8M→$8.8M3 prior comparisons
Working capital changed across a sign change
Working capital changed -121.5% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a sign change.
$7.2M→-$1.6M4 prior comparisons
Inventory / revenue moved 2940 bp lower
Inventory / revenue changed -2940 basis points from the comparable as-filed period.
29.74%→0.34%3 prior comparisons
Receivables / revenue moved 5728 bp higher
Receivables / revenue changed +5728 basis points from the comparable as-filed period.
95.20%→152.47%3 prior comparisons
R&D / revenue moved 478 bp lower
R&D / revenue changed -478 basis points from the comparable as-filed period.
13.55%→8.77%3 prior comparisons
Total assets decreased 7.4%
Total assets changed -7.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$67.9M→$62.9M4 prior comparisons
Shares outstanding increased 0.2%
Shares outstanding changed +0.2% from the comparable as-filed period. The change ranks at the 12th percentile of 8 prior comparable changes.
14,959,937→14,983,1078 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.